Al. Gard et al., ASTROGLIAL CONTROL OF OLIGODENDROCYTE SURVIVAL MEDIATED BY PDGF AND LEUKEMIA INHIBITORY FACTOR-LIKE PROTEIN, Development, 121(7), 1995, pp. 2187-2197
Programmed death and the identification of growth factors delaying thi
s process in the oligodendrocyte lineage suggest that other cell types
provide oligodendrogliotrophins. To determine their source, primary c
ultures of oligodendroblasts immunopurified from postnatal rat cerebru
m were used to screen other cultured neural and non-neural cell types
for the release of survival factors into a defined insulin-containing
medium, In non-conditioned medium, oligodendroblasts died 1-2 days aft
er undergoing terminal differentiation into oligodendrocytes, as defin
ed by the onset of expression of galactocerebroside. In medium conditi
oned by astrocytes, unlike the other tested cell types, differentiated
oligodendrocytes survived for weeks in a mature myelinogenic state. S
urvival was partially reduced by immunoabsorption of the medium with a
ntibodies to platelet-derived growth factor and abolished by immunoabs
orption with antibodies to leukemia inhibitory factor, By the same cri
terion, survival activity was not attributed to other astrocytic produ
cts, ciliary neurotrophic factor and basic fibroblast growth factor. M
embrane ultrafiltration analysis indicated the activity corresponded t
o heat-labile protein smaller (M(r) = 10-30x10(3)) than native rat leu
kemia inhibitory factor (M(r) = 43x10(3)). The astrocytic stimulus was
>4-fold more efficacious than other known oligodendrogliotrophic cyto
kines, including ciliary neurotrophic factor, neurotrophin-3 and leuke
mia inhibitory factor itself, tested singly or in combination, and pro
moted survival additively with these agents, These findings suggest th
at astrocytes function as paracrine regulators of oligodendroblast and
oligodendrocyte survival and that their effect is mediated initially
by platelet-derived growth factor and thereafter by a powerful cytokin
e related to leukemia inhibitory factor.